Skip to content
Insider tapeFilings through Fri, Oct 16
Watchlist

Stephen L Sabba

Director at Ligand Pharmaceuticals Inc (LGND)

Purchase track record

Not enough history. Based on 0 purchases with a full 90 days of price history.

—
Avg. 90-day return—
vs. S&P 500—
Beat the market—
Paper profit on buys$0
Total bought / sold$0 / $1.2M

Reported trades

Filed Stock Type Shares Price Value Since
Jun 18SEC LGNDLigand Pharmaceuticals Inc Sell 2,14533,629 held (−6%) $254.00 $545K +16.4%
Mar 25SEC LGNDLigand Pharmaceuticals Inc Sell 1,00032,793 held (−3%) $207.87 $208K +42.2%
Mar 5SEC LGNDLigand Pharmaceuticals Inc Sell 2,03433,793 held (−6%) $201.50 $410K +46.7%